8. Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in…
Fig. 2.1 Macrophage has multiple critical roles during differentiation of HPC to hepatocytes. During liver damage TWEAK expressing macrophage stimulates HPC expansion. Hepatocyte debris eating macrophage determine the fate of…
© Springer Japan 2016Shuji Terai and Takeshi Suda (eds.)Gene Therapy and Cell Therapy Through the Liver10.1007/978-4-431-55666-4_1 1. Liver-Targeted Gene and Cell Therapies: An Overview Mohammad Alsaggar1 and Dexi Liu1 (1) Department of Pharmaceutical and Biomedical Sciences, University…
Fig. 12.1 Risk categories of first–third-class regenerative medicine technologies To implement a plan for the provision of first-class regenerative medicine, the provider is required to submit a plan to the…
Medical factors Failure of medical therapy Probability of survival without transplant MELD score Pulmonary status Renal failure Infection Surgical factors Probability of survival with transplant Age BMI Technical complexity (anatomic…
Fig. 5.1 Absolute number of liver transplants for patients with PBC by year [6] 5.3 Survival Following Liver Transplantation for PBC Patient and graft survival for PBC are excellent compared…
Fig. 14.1 Metastatic cholangiocarcinoma to the liver Fig. 14.2 Retroaortic/retrocaval recurrent cholangiocarcinoma Fig. 14.3 Lytic metastases to the (a) iliac bone and (b) spine Fig. 14.4 Pulmonary metastatic cholangiocarcinoma Pathologic…
Author/institution Proposed expanded criteria Radiology/path 5-year survival Yao, UCSF [14] 1 nodule ≤6.5 cm, or 2–3 nodules ≤4.5 cm and total tumor diameter ≤8 cm Pathology MC—72 % EC—73 %…
Fig. 17.1 Breakdown of etiology of disease leading to liver transplantation, adapted from Singal et al. [1]. Abbreviations: CC cryptogenic cirrhosis, CCLD chronic cholestatic liver disease, HBV hepatitis B virus,…
New waitlist registrants 2004 New waitlist registrants 2013 Percentage increase (%) Hepatitis C 2887 3291 14 Alcoholic liver disease 1400 2024 45 Nonalcoholic fatty liver disease 804 2174 170…
